Cargando…

Evaluating the Clinical Impact of a Genomic Classifier in Prostate Cancer Using Individualized Decision Analysis

BACKGROUND: Currently there is controversy surrounding the optimal way to treat patients with prostate cancer in the post-prostatectomy setting. Adjuvant therapies carry possible benefits of improved curative results, but there is uncertainty in which patients should receive adjuvant therapy. There...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lobo, Jennifer Mason, Dicker, Adam P., Buerki, Christine, Daviconi, Elai, Karnes, R. Jeffrey, Jenkins, Robert B., Patel, Nirav, Den, Robert B., Showalter, Timothy N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383561/ https://www.ncbi.nlm.nih.gov/pubmed/25837660 http://dx.doi.org/10.1371/journal.pone.0116866

Ejemplares similares

Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
por: Erho, Nicholas, et al.
Publicado: (2013)

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery
por: Badani, Ketan K, et al.
Publicado: (2015)

Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy
por: Den, Robert B., et al.
Publicado: (2014)

Towards decision-making using individualized risk estimates for personalized medicine: A systematic review of genomic classifiers of solid tumors
por: Trifiletti, Daniel M., et al.
Publicado: (2017)

Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer
por: Erho, Nicholas, et al.
Publicado: (2012)

Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group
por: Badani, Ketan, et al.
Publicado: (2013)

Prostate cancer in young men represents a distinct clinical phenotype: gene expression signature to predict early metastases
por: Ding, Yuan C., et al.
Publicado: (2021)

Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race
por: Kensler, Kevin H., et al.
Publicado: (2022)

Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers
por: Vergara, Ismael A., et al.
Publicado: (2012)

A comparative study of PCS and PAM50 prostate cancer classification schemes
por: Yoon, Junhee, et al.
Publicado: (2021)

Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer
por: Liu, Deli, et al.
Publicado: (2018)

Radiation Therapy after Radical Prostatectomy for Prostate Cancer: Evaluation of Complications and Influence of Radiation Timing on Outcomes in a Large, Population-Based Cohort
por: Hegarty, Sarah E., et al.
Publicado: (2015)

Interpretation of microbiota-based diagnostics by explaining individual classifier decisions
por: Eck, A., et al.
Publicado: (2017)

Providing guidance for genomics-based cancer treatment decisions: insights from stakeholder engagement for post-prostatectomy radiation therapy
por: Abe, James, et al.
Publicado: (2017)

Commissioning and implementation of an implantable dosimeter for radiation therapy
por: Buzurovic, Ivan, et al.
Publicado: (2013)

Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1
por: Spans, Lien, et al.
Publicado: (2016)

Re-implantation of suboptimal prostate seed implantation: technique with intraoperative treatment planning
por: Doyle, Laura, et al.
Publicado: (2012)

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
por: Stoyanova, Radka, et al.
Publicado: (2016)

Risk-prediction tools in prostate cancer: the challenge of tailoring
por: Morlacco, Alessandro, et al.
Publicado: (2016)

Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial
por: Feng, Felix Y., et al.
Publicado: (2021)

Use of the Decipher genomic classifier among men with prostate cancer in the United States
por: Zaorsky, Nicholas G, et al.
Publicado: (2023)

Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial
por: Tosco, Lorenzo, et al.
Publicado: (2018)

Vitamins and Prostate Cancer Risk
por: Donkena, Krishna Vanaja, et al.
Publicado: (2010)

VariantClassifier: A hierarchical variant classifier for annotated genomes
por: Li, Kelvin, et al.
Publicado: (2010)

What is the Need for Prostatic Biomarkers in Prostate Cancer Management?
por: Spahn, Martin, et al.
Publicado: (2015)

Advances in Radiotherapy for Prostate Cancer Treatment
por: Podder, Tarun, et al.
Publicado: (2016)

Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance
por: Nouri, Mannan, et al.
Publicado: (2017)

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients
por: Alshalalfa, Mohammed, et al.
Publicado: (2017)

Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer
por: Feng, Ye, et al.
Publicado: (2019)

On Pixel-Wise Explanations for Non-Linear Classifier Decisions by Layer-Wise Relevance Propagation
por: Bach, Sebastian, et al.
Publicado: (2015)

Decision tree–based classifier in providing telehealth service
por: Chern, Ching-Chin, et al.
Publicado: (2019)

Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics
por: Moschini, Marco, et al.
Publicado: (2016)

Systematic Review of the Relationship between Acute and Late Gastrointestinal Toxicity after Radiotherapy for Prostate Cancer
por: Peach, Matthew Sean, et al.
Publicado: (2015)

Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
por: Yang, Lingjian, et al.
Publicado: (2018)

The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer
por: Prensner, John R., et al.
Publicado: (2014)

Factors that influence patient preferences for prostate cancer management options: A systematic review
por: Showalter, Timothy N, et al.
Publicado: (2015)

Robust Framework to Combine Diverse Classifiers Assigning Distributed Confidence to Individual Classifiers at Class Level
por: Khalid, Shehzad, et al.
Publicado: (2014)

Immunophenotyping of normal individuals classified on the basis of human dosha prakriti
por: Rotti, Harish, et al.
Publicado: (2014)

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma
por: Alshalalfa, Mohammed, et al.
Publicado: (2019)

Commentary: Classifying descending necrotizing mediastinitis: What's the upshot?
por: Cameron, Robert B.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mtrftu6ir63p3usg4ke0vkhjn9